Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,750 | 1,813 | 523 | 57,860 | 97,637 |
| Gross Profit | 1,750 | 1,813 | 523 | 57,860 | 97,637 |
| Operating Expenses | 15,552 | 9,322 | 10,643 | 65,998 | 107,382 |
| Operating Income | -13,802 | -7,509 | -10,120 | -8,138 | -9,745 |
| Interest Expense | 1,478 | 0 | 0 | 86 | 132 |
| Other Income | 518 | 896 | 154 | 1,125 | 1,348 |
| Pre-tax Income | -14,762 | -6,613 | -9,966 | -7,099 | -8,529 |
| Income Tax | N/A | N/A | N/A | -101 | N/A |
| Net Income Continuous | -14,762 | -6,613 | -9,966 | -6,998 | -8,529 |
| Net Income | $-14,762 | $-6,613 | $-9,966 | $-6,998 | $-8,529 |
| EPS Basic Total Ops | -749.48 | -4,043.71 | -6,134.12 | -330.32 | -424.70 |
| EPS Basic Continuous Ops | -750.24 | -4,039.24 | -6,137.29 | -328.82 | -424.05 |
| EPS Diluted Total Ops | -749.48 | -4,043.71 | -6,134.12 | -330.32 | -424.70 |
| EPS Diluted Continuous Ops | -750.24 | -4,039.24 | -6,137.29 | -328.82 | -424.05 |
| EBITDA(a) | $-13,332 | $-6,829 | $-9,146 | $-4,989 | $-6,354 |